(Q54544469)

31 May 2018

title

Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma. (English)

1 reference

31 May 2018

esophageal squamous cell carcinoma

main subject

1 reference

Dongli Yue

1

1 reference

31 May 2018

Qingxia Fan

2

1 reference

31 May 2018

Xinfeng Chen

3

1 reference

31 May 2018

Feng Li

4

1 reference

31 May 2018

Liping Wang

5

1 reference

31 May 2018

Lan Huang

6

1 reference

31 May 2018

Wenjie Dong

7

1 reference

31 May 2018

Xiaoqi Chen

8

1 reference

31 May 2018

Zhen Zhang

9

1 reference

31 May 2018

Jinyan Liu

10

1 reference

31 May 2018

Fei Wang

11

1 reference

31 May 2018

Meng Wang

12

1 reference

31 May 2018

Bin Zhang

13

1 reference

31 May 2018

Yi Zhang

14

1 reference

31 May 2018

language of work or name

English

0 references

publication date

21 November 2013

1 reference

31 May 2018

Experimental Cell Research

published in

1 reference

31 May 2018

volume

322

1 reference

31 May 2018

issue

1

1 reference

31 May 2018

page(s)

149-158

1 reference

31 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

7 January 2021

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Population attributable risks of esophageal and gastric cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Characterization of placental bikunin, a novel human serine protease inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Mechanisms of caspase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

p53 protein expression and prognosis in squamous cell carcinoma of the esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Hepatocyte growth factor: a multifunctional cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

Cancer epigenomics: DNA methylomes and histone-modification maps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

The hepatocyte growth factor regulatory factors in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.11.009

10.1016/J.YEXCR.2013.11.009

7 January 2021

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018